H71.3
Diffuse cholesteatosis
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse cholesteatosis is a rare condition involving the abnormal growth of keratinizing squamous epithelium within the middle ear or mastoid air cells. It is characterized by the proliferation of skin-like tissue, which can lead to the destruction of surrounding structures if left untreated. Often associated with long-standing ear infections or other ear conditions, this disease requires careful diagnosis and management to prevent complications such as hearing loss.
Causes & Symptoms
Clinical Causes: Chronic otitis media (long-standing middle ear infection) Previous ear surgeries or trauma Eustachian tube dysfunction Malformation or abnormalities of the middle ear structures Genetic predispositions related to skin cell proliferation
Key Symptoms: Hearing loss, typically gradual A feeling of fullness or pressure in the ear Otorrhea (ear discharge), especially if infected Tinnitus (ringing or buzzing in the ear) Dizziness or balance issues in some cases Discharge that may be foul-smelling if secondary infection occurs
Diagnostic & Treatment
Diagnosis Path: Diagnosis of diffuse cholesteatosis involves a comprehensive clinical assessment, including a detailed history and physical examination of the ear. Key diagnostic tools include:
Treatment Protocols: Managing diffuse cholesteatosis typically requires surgical intervention to remove the abnormal tissue and repair any damage. Treatment approaches include:
Clinical Advice & FAQs
Billing Guidance
Is H71.3 a billable ICD-10 code?
Yes, H71.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H71.3?
Clinical documentation must specify the nature of Diffuse cholesteatosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference